Insights

Expanding Diagnostic Portfolio Eurofins Viracor BioPharma's recent launch of advanced molecular assays such as quantitative PCR for Chagas disease and dimorphic fungi indicates their commitment to expanding rapid and accurate infectious disease testing capabilities, presenting opportunities to offer complementary diagnostic technologies or custom assay development services.

High Throughput and Scalability With their capacity to process large sample volumes quickly and support trials of any size, Eurofins Viracor is positioned to benefit from partnerships that enhance laboratory automation, sample management solutions, and data integration tools to further optimize lab throughput and operational efficiency.

Innovation in Immunology The launch of tests evaluating T-cell mediated immunity and immune responses to viruses like Epstein-Barr highlights their focus on immunology research, creating opportunities for technology providers specializing in immune assay platforms, data analytics, or next-generation sequencing integration.

Market Diversification Their broad service scope across infectious diseases, vaccine efficacy, and biomarker analysis signals potential sales opportunities with companies seeking comprehensive clinical trial testing solutions, especially those exploring new therapeutics in infectious and immunological spaces.

Web and Cloud Technology Use Eurofins Viracor’s utilization of cloud services and modern web technologies suggests openness to partnerships involving digital transformation, secure cloud-based data management, and remote sample tracking solutions to enhance their operational agility and data security.

Eurofins Viracor BioPharma Services Tech Stack

Eurofins Viracor BioPharma Services uses 8 technology products and services including ISO 13485, Open Graph, Google Docs, and more. Explore Eurofins Viracor BioPharma Services's tech stack below.

  • ISO 13485
    Certificates
  • Open Graph
    Content Management System
  • Google Docs
    Documentation Tools
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • Microsoft Windows
    Operating Systems
  • HSTS
    Security
  • ImageJ
    Software Development
  • Adobe Creative Suite
    Visualisation Software

Media & News

Eurofins Viracor BioPharma Services's Email Address Formats

Eurofins Viracor BioPharma Services uses at least 2 format(s):
Eurofins Viracor BioPharma Services Email FormatsExamplePercentage
FirstLast@eurofins-viracor.comJohnDoe@eurofins-viracor.com
95%
Last@eurofins-viracor.comDoe@eurofins-viracor.com
2%
First@eurofins-viracor.comJohn@eurofins-viracor.com
2%
FirLast@eurofins-viracor.comJohDoe@eurofins-viracor.com
1%

Frequently Asked Questions

Where is Eurofins Viracor BioPharma Services's headquarters located?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services's main headquarters is located at 18000 West 99th Street Overland Park, Kansas 66219 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Eurofins Viracor BioPharma Services's official website and social media links?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services's official website is eurofins-viracorbiopharma.com and has social profiles on LinkedIn.

What is Eurofins Viracor BioPharma Services's SIC code NAICS code?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eurofins Viracor BioPharma Services have currently?

Minus sign iconPlus sign icon
As of May 2026, Eurofins Viracor BioPharma Services has approximately 95 employees across 2 continents, including North AmericaEurope. Key team members include President: S. M.Vice President: D. S.Vice President, Finance: D. K.. Explore Eurofins Viracor BioPharma Services's employee directory with LeadIQ.

What industry does Eurofins Viracor BioPharma Services belong to?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services operates in the Biotechnology Research industry.

What technology does Eurofins Viracor BioPharma Services use?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services's tech stack includes ISO 13485Open GraphGoogle DocsISO/IEC 27001Microsoft WindowsHSTSImageJAdobe Creative Suite.

What is Eurofins Viracor BioPharma Services's email format?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services's email format typically follows the pattern of FirstLast@eurofins-viracor.com. Find more Eurofins Viracor BioPharma Services email formats with LeadIQ.

When was Eurofins Viracor BioPharma Services founded?

Minus sign iconPlus sign icon
Eurofins Viracor BioPharma Services was founded in 1983.

Eurofins Viracor BioPharma Services

Biotechnology ResearchKansas, United States51-200 Employees

Eurofins Viracor BioPharma is a trusted provider of drug development solutions to pharmaceutical and contract research organizations. We offer complex/esoteric testing and assay development, to help advance your Phase 1-4 clinical trials through trusted partnership, scientific excellence, and exceptional service.

For more than 40 years, Eurofins Viracor BioPharma has been dedicated to helping clients by providing high-quality, accurate results to evaluate the effects of drug candidates across all major therapeutic categories. We offer broad experience in molecular infectious disease testing, vaccine safety and efficacy assessment, immunogenicity, cell-based assays, allergy/hypersensitivity, and biomarker analysis. Our validated test list includes more than 3,000 assays, with new custom assays developed on a continual basis, in response to client needs.

Expertise
We’re driven to partner with you to solve difficult scientific problems, complementing your strategies with expertise in complex method development on multiple technology platforms, validation, and transfer. Our Research & Development team serves as an extension of your laboratory, with unique skills in technology platform selection and protocol design.

Agility
Eurofins Viracor BioPharma leverages over 40 different technology platforms and accepts a broad range of specimen types, widening our capabilities and enabling us to customize testing to your exact needs for your clinical trial combined with the scalability to manage trials of any size. We adhere to GCLP guidelines.

Speed
Our high-throughput laboratory can support your clinical trials with the capacity to process large sample volumes quickly, support studies with short set up timelines and provide rapid turnaround times. Our project managers and scientists act as part of your team – going above and beyond to get you the results you need when you need them. Accelerating your vaccine, compound, immune therapy or biological from bench to market.

Section iconCompany Overview

Headquarters
18000 West 99th Street Overland Park, Kansas 66219 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1983
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    Eurofins Viracor BioPharma Services's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Eurofins Viracor BioPharma Services's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.